knowledge -WSS

knowledge

author：Wikipedia 2025-09-14 14:46:06 - browse：176

Silver Apple Watch — Charles Rex Arbogast/AP

Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders.

Rune in 2022 received Food and Drug Administration clearance for StrivePD, an Apple Watch app that uses the device’s sensors to track two Parkinson’s-related symptoms: tremors and dyskinesia, or the involuntary movements that are a side effect of medication. The app also collects sleep, activity, and medication data and can serve as a focal point for education and care management for people with Parkinson’s. The app can help users make day-to-day decisions about lifestyle and medication and help inform care decisions by providers. Rune also works with drug companies developing treatments for the disease.

Rune Labs CEO Brian Pepin told STAT the company will use the funds to push the adoption of its technology among health plans that can use it to manage care for their members with Parkinson’s disease. The company last year finalized a deal with “a large California health system” and now hopes to go out and sell to more organizations that have Medicare Advantage plans or other at-risk populations they serve. This requires an investment in business development staff and people to manage those relationships.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Ebola: Gilead Sciences antiviral shows promise as new treatment

entertainment

WSS

J&J to emphasize cancer drugs, stop much of its vaccine research

FDA advisers back CAR

What don’t we know about an Alzheimer’s drug side effect?

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Will the market for weight loss drugs really reach $100 billion?

RaDonda Vaught links Vanderbilt hospital issues to patient death

focus

knowledge

explore

23andMe had bad news about my health. I wish a person had delivered it

First U.S. drug developed to treat liver disease MASH is approved

Supreme Court strikes down use of affirmative action

What don’t we know about an Alzheimer’s drug side effect?

Affirmative action in medical school literally saved lives

Medicare coverage of Wegovy, once blocked, now looks possible

Cancer drug shortages should be causing more outrage

UCLA team creates talking throat patch for voice disorders

Medical leaders decry Supreme Court decision on affirmative action

Pediatric cancer treatments threatened by a new FDA policy

hotspot

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

FDA investigates CAR

What don’t we know about an Alzheimer’s drug side effect?

UCLA team creates talking throat patch for voice disorders

How many hemophilia patients actually want gene therapy?

Why depression after traumatic brain injury is distinct

hotspot

knowledge

entertainment

focus